High plasma levels of phytosterols in patients on parenteral nutrition: a marker of liver dysfunction.

L. Bindl,D. Lütjohann,S. Buderus,M. J. Lentze,K. V. Bergmann

DOI: https://doi.org/10.1097/00005176-200009000-00022

1999-05-01

Abstract:Parenteral nutrition–associated cholestatic liver disease (PNAC) is considered to be multifactorial in origin, and its incidence has decreased during the past years (1). The pathogenesis of PNAC, however, remains poorly understood.Commercially available intravenous fat emulsions are soy-based preparations containing the phytosterols (PS) sitosterol, campesterol, and sigmasterol at a total concentration of approximately 1000 mol/L (40 mg/dL). The observation of high plasma levels of PS in patients with PNAC, receiving intravenous fat emulsions, led to the hypothesis that accumulation of these substances contributes to cholestasis (2–4). An animal model, disclosing decreased bile flow induced by infusion of PS (3), supported the assumption. In this study, we monitored the sitosterol plasma concentrations in a heterogeneous group of patients with liver dysfunction during parenteral nutrition (PN). Plasma concentrations of sitosterol were measured, using accurate gas-liquid chromatography-mass spectrometry techniques, as previously described (5). In total, we analyzed five patients on PN. Three of the five patients developed steatosis with non-icteric hepatic dysfunction. Their course improved with reduced glucose infusionrates while the dosage of lipid emulsions remained unchanged. Measurements of plasma sitosterol were continued in two patients with severe PNAC after stopping or reducing fat infusion.